Propha-Masteron 100 - Beligas Pharmaceuticals

Drostanolone propionate, commonly branded as Masteron, was initially developed in 1959 by Syntex Pharmaceuticals for treating advanced breast cancer. Its DHT-derived structure offers powerful anti-estrogenic effects, eliminating water retention and enhancing muscle hardness. The Syntex release brought drostanolone to prominence, eventually catching the attention of athletes for its ability to produce a dense, lean physique ideal for cutting phases. While initially aimed at medical treatments, Masteron gained popularity in bodybuilding for its non-aromatizing effects, helping athletes achieve sharper muscle definition.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Propha-Masteron 100 by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.